Therefore, in this study we used a sensitive RT-PCR–based assay with fluorescent fragment analysis to explore the possibility that MPN patients may commonly express this JAK2 mRNA splice variant at levels that cannot be reliably detected by sequence analysis. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.